90 related articles for article (PubMed ID: 6173454)
21. Subcellular distribution of androgen receptors in human normal, benign hyperplastic, and malignant prostatic tissues: characterization of nuclear salt-resistant receptors.
Barrack ER; Bujnovszky P; Walsh PC
Cancer Res; 1983 Mar; 43(3):1107-16. PubMed ID: 6186370
[TBL] [Abstract][Full Text] [Related]
22. Towards a reproducible method of estimating androgen receptors in human prostate.
Smith T; Chisholm GD; Habib FK
J Steroid Biochem; 1983 May; 18(5):531-4. PubMed ID: 6602248
[TBL] [Abstract][Full Text] [Related]
23. [Usefulness of molybdate in the determination of androgen receptors in various tissues].
Dubé JY; Tremblay RR
Union Med Can; 1980 Apr; 109(4):495-7. PubMed ID: 7456144
[No Abstract] [Full Text] [Related]
24. Effects of sodium molybdate on the androgen receptor from the R3327 prostatic tumor.
Rowley DR; Chang CH; Tindall DJ
Endocrinology; 1984 May; 114(5):1776-83. PubMed ID: 6714164
[TBL] [Abstract][Full Text] [Related]
25. Effect of molybdate on androgen receptor levels in canine prostate.
Naritoku WY; Howard EB; Britt JO; Markland FS
Prostate; 1982; 3(6):611-4. PubMed ID: 7155993
[TBL] [Abstract][Full Text] [Related]
26. Increased recovery of androgen receptors from human prostate through the use of mersalyl: evidence for androgen regulation of the binding sites in carcinomatous prostate.
de Larminat MA; Pasik L; Bellora O; Arturi J; Scorticati C
Prostate; 1986; 9(1):97-108. PubMed ID: 2426691
[TBL] [Abstract][Full Text] [Related]
27. Tamoxifen decreases progesterone and nuclear androgen receptors in the human prostate.
Albert JD; Geller J; Liu JD; Faber LE
J Steroid Biochem; 1984 Dec; 21(6):659-62. PubMed ID: 6084754
[TBL] [Abstract][Full Text] [Related]
28. Effect of molybdate on activation and stabilization of steroid receptors.
Noma K; Nakao K; Sato B; Nishizawa Y; Matsumoto K; Yamamura Y
Endocrinology; 1980 Oct; 107(4):1205-11. PubMed ID: 7408768
[TBL] [Abstract][Full Text] [Related]
29. The effect of molybdate on the intracellular distribution of estrogen receptor in mammary tumors.
Lazier CB; Richman J; Lonergan K
Breast Cancer Res Treat; 1984; 4(1):19-26. PubMed ID: 6697008
[TBL] [Abstract][Full Text] [Related]
30. Nuclear androgen receptor assay in biopsy-size specimens of human prostatic tissue.
Blankenstein MA; Bolt-de Vries J; Foekens JA
Prostate; 1982; 3(4):351-9. PubMed ID: 7122332
[TBL] [Abstract][Full Text] [Related]
31. Benign prostatic hyperplasia--video image analysis and its relationship to androgen and epidermal growth factor receptor expression.
Frydenberg M; Foo TM; Jones AS; Grace J; Hensley WJ; Rogers J; Pearson BS; Raghavan D
J Urol; 1991 Sep; 146(3):872-6. PubMed ID: 1714972
[TBL] [Abstract][Full Text] [Related]
32. Effect of androgen on androgen receptors in cultured human epididymis.
Vázquez MH; de Larminat MA; Blaquier JA
J Endocrinol; 1986 Nov; 111(2):343-8. PubMed ID: 3794586
[TBL] [Abstract][Full Text] [Related]
33. Steroid receptor content in cytosol from normal and hyperplastic human prostates.
Ekman P; Snochowski M; Dahlberg E; Bression D; Högberg B; Gustafsson JA
J Clin Endocrinol Metab; 1979 Aug; 49(2):205-15. PubMed ID: 88456
[TBL] [Abstract][Full Text] [Related]
34. Characterization of unoccupied (R) and occupied (RA) androgen binding components of the hyperplastic human prostate.
Shain SA; Boesel RW; Lamm DL; Radwin HM
Steroids; 1978 Apr; 31(4):541-56. PubMed ID: 78551
[TBL] [Abstract][Full Text] [Related]
35. Characterization and measurement of the androgen receptor in human benign prostatic hyperplasia and prostatic hyperplasia and prostatic carcinoma.
Snochowski M; Pousette A; Ekman P; Bression D; Andersson L; Högberg B; Gustafsson JA
J Clin Endocrinol Metab; 1977 Nov; 45(5):920-30. PubMed ID: 72758
[No Abstract] [Full Text] [Related]
36. Progestin binding in benign hyperplastic prostatic tissue.
Sirett DA
J Steroid Biochem; 1983 Jul; 19(1A):163-7. PubMed ID: 6193339
[TBL] [Abstract][Full Text] [Related]
37. Differential effects of molybdate on the hydrodynamic and DNA-binding properties of the non-activated and activated forms of the androgen receptor in calf uterus.
de Boer W; Bolt J; Brinkmann AO; Mulder E
Biochim Biophys Acta; 1986 Nov; 889(2):240-50. PubMed ID: 3778950
[TBL] [Abstract][Full Text] [Related]
38. Cytoplasmic and nuclear androgen receptor content of normal and neoplastic human prostates and lymph node metastases of human prostatic adenocarcinoma.
Shain SA; Boesel RW; Lamm DL; Radwin HM
J Clin Endocrinol Metab; 1980 Apr; 50(4):704-11. PubMed ID: 6154061
[No Abstract] [Full Text] [Related]
39. Androgen-binding proteins in human benign prostatic hypertrophy.
Rosen V; Jung I; Baulieu EE; Robel P
J Clin Endocrinol Metab; 1975 Oct; 41(4):761-70. PubMed ID: 51854
[TBL] [Abstract][Full Text] [Related]
40. Histochemical detection of steroid hormone receptors in the human prostate.
Pertschuk LP; Zava DT; Tobin EH; Brigati DJ; Gaetjens E; Macchia RJ; Wise GJ; Wax HS; Kim DS
Prog Clin Biol Res; 1979; 33():113-32. PubMed ID: 93748
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
